Neffen H, Baena-Cagnani C E, Malka S, Solé D, Sepúlveda R, Caraballo L, Caravajal E, Rodríguez Gavaldá R, González Díaz S, Guggiari Chase J, Díez C, Baluga J, Capriles Hulett A
Ricardo Gutiérrez Children's Hospital, Allergy Unit, Santa Fe, Argentina.
J Investig Allergol Clin Immunol. 1997 Jul-Aug;7(4):249-53.
There are not enough data concerning asthma mortality in Latin America. The Latin American Society of Allergy and Immunology coordinated this project to provide reliable data for gaining knowledge about our present situation, which is a condition indispensable to changing it. The following countries participated in this study: Argentina, Brazil, Chile, Colombia, Costa Rica, Cuba, Mexico, Paraguay, Peru, Uruguay and Venezuela. A uniform protocol was designed in Santa Fe, Argentina. Asthma mortality rates were analyzed in accordance with two variables: age-adjusted rates (5-34) and total death rates. The total population studied was 107, 122, 529 inhabitants. The highest death rates were found in Uruguay and Mexico (5.63), and the lowest in Paraguay (0.8) and Colombia (1.35). Age-adjusted (5-34) rates were higher in Costa Rica (1.38) and lower in Chile (0.28). Regarding sex, the analysis of the information provided by seven countries showed a predominance of females (51.8%) over males (48.18%). In the southern Latin American countries such as Chile, Uruguay, Paraguay and Argentina, which have marked climatic differences, deaths occurred mainly in the winter. It is important to emphasize that, in most countries, deaths from asthma occurred at home: Chile (60.7%), Argentina (63.4%) and Paraguay (88%). However, in Uruguay, 58.6% occurred during hospitalization. Mortality rates from bronchial asthma are high in most of the Latin American countries studied, even though further studies are needed. Asthma is a serious global health problem. People of all ages in countries throughout the world are affected by this chronic airway disorder that can be severe and sometimes fatal. The health ministries of each country do not believe asthma is a significant issue. Therefore, we should provide them with sound epidemiological studies to convince them to change their attitude toward this disease.
关于拉丁美洲哮喘死亡率的数据不足。拉丁美洲过敏和免疫学协会协调了这个项目，以提供可靠的数据来了解我们目前的状况，这是改变现状不可或缺的条件。以下国家参与了这项研究：阿根廷、巴西、智利、哥伦比亚、哥斯达黎加、古巴、墨西哥、巴拉圭、秘鲁、乌拉圭和委内瑞拉。在阿根廷的圣菲设计了统一的方案。根据两个变量分析哮喘死亡率：年龄调整率（5 - 34岁）和总死亡率。研究的总人口为107122529名居民。死亡率最高的是乌拉圭和墨西哥（5.63），最低的是巴拉圭（0.8）和哥伦比亚（1.35）。年龄调整后（5 - 34岁）的比率在哥斯达黎加较高（1.38），在智利较低（0.28）。关于性别，对七个国家提供的信息分析显示女性（51.8%）多于男性（48.18%）。在气候差异明显的拉丁美洲南部国家，如智利、乌拉圭、巴拉圭和阿根廷，死亡主要发生在冬季。需要强调的是，在大多数国家，哮喘死亡发生在家里：智利（60.7%）、阿根廷（63.4%）和巴拉圭（88%）。然而，在乌拉圭，58.6%的死亡发生在住院期间。在所研究的大多数拉丁美洲国家，支气管哮喘的死亡率很高，尽管还需要进一步研究。哮喘是一个严重的全球健康问题。全世界各国各年龄段的人都受到这种慢性气道疾病的影响，这种疾病可能很严重，有时甚至致命。每个国家的卫生部都不认为哮喘是一个重要问题。因此，我们应该为他们提供可靠的流行病学研究，以说服他们改变对这种疾病的态度。
